Introduction
============

RNA recombination plays a central role in the evolution of animal, plant, and bacterial RNA viruses as it facilitates the elimination of debilitating or lethal mutations. The importance of RNA recombination is further illustrated by the resulting alterations of the biological properties of RNA viruses including changes in virulence and host range, and even by the emergence of new pathogens and diseases ([@evx046-B61]; [@evx046-B10]). To explain the mechanism of RNA recombination, two major models have been suggested. For several positive-strand RNA viruses, it has been demonstrated in cell-free systems that the viral RNA-dependent RNA polymerases (RdRp) are able to perform a template switch during viral RNA synthesis ([@evx046-B13]; [@evx046-B2]; [@evx046-B33]; [@evx046-B15]). In contrast, only few studies have described nonreplicative RNA recombination. Experiments in tissue culture cells with synthetic RNAs derived from bovine viral diarrhea virus (BVDV) and poliovirus clearly proved the existence of a nonreplicative RNA recombination mechanism in the absence of a functioning viral RdRp ([@evx046-B24]; [@evx046-B20]). Similar results have been recently reported for analogous experiments with synthetic genome fragments derived from Hepatitis C virus (HCV) ([@evx046-B49]). Furthermore, for poliovirus and BVDV efficient nonreplicative joining of RNA fragments is significantly influenced by the 5′ and 3′ terminal groups of the recombining RNA molecules ([@evx046-B24]; [@evx046-B3]). This supports the hypothesis that nonreplicative RNA recombination is based on endoribonucleolytic cleavage or cryptic ribozyme activity of RNA molecules, followed by a ligation reaction of the RNA fragments. Hence, it is conceivable that viral proteins might play an important role in nonreplicative RNA recombination, in particular when considering the fact that some of the pestiviral proteins directly interact with RNA ([@evx046-B62]; [@evx046-B27]; [@evx046-B28]; [@evx046-B41]; [@evx046-B22]).

Pestiviruses like BVDV-1, BVDV-2, classical swine fever virus (CSFV), and border disease virus (BDV) are economically important livestock pathogens worldwide. The genus *Pestivirus* belongs to the family *Flaviviridae* together with the genera *Hepacivirus*, *Flavivirus*, and *Pegivirus* ([@evx046-B52]). The positive-sense single-stranded RNA genome of pestiviruses has a length of about 12.3 kb and consists of one single open reading frame (ORF) coding for one large polyprotein, which is co and posttranslationally processed by viral and cellular proteases into the structural proteins C (core), E^rns^, E1, and E2, and the nonstructural (NS) proteins N^pro^, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B ([@evx046-B11]; [@evx046-B52]). The ORF is flanked by 5′ and 3′ nontranslated regions (NTRs) ([@evx046-B18]). Translation of pestiviral proteins occurs cap-independent and is mediated by an essential internal ribosomal entry site (IRES) located in the 5′NTR ([@evx046-B45]; [@evx046-B43]). The first protein encoded by the ORF is the unique pestivirus-specific N-terminal protease (N^pro^), which generates its own C-terminus plus the N-terminus of C protein by autoproteolytic cleavage ([@evx046-B60]; [@evx046-B53]). N^pro^ is dispensable for viral replication ([@evx046-B58]). The C-terminus of C protein is produced by an intramembrane signal peptide peptidase cleavage ([@evx046-B26]). The C protein is a highly basic and intrinsically disordered protein that binds RNA with a low affinity and specificity and possesses RNA chaperone activity ([@evx046-B28]; [@evx046-B41]). The glycoprotein E^rns^ has endoribonuclease activity and represents the second unique protein exclusively encoded by members of the genus *Pestivirus* ([@evx046-B50]). E^rns^ could contribute to the generation of substrates for RNA recombination by endonucleolytic cleavage of RNA molecules and thus might be significantly implicated in viral RNA recombination. NS3 possesses helicase and NTPase activities ([@evx046-B55]; [@evx046-B59]). For NS4B, an NTPase motif has been described ([@evx046-B22]), whereas NS5B is the viral RNA-dependent RNA polymerase ([@evx046-B62]; [@evx046-B31]; [@evx046-B54]).

According to their effects on tissue culture cells, a cytopathogenic (cp) and a noncytopathogenic (ncp) biotype of pestiviruses can be distinguished ([@evx046-B35]; [@evx046-B21]). The emergence of cp BVDV strains by nonhomologous RNA recombination in cattle persistently infected with ncp BVDV is directly linked to the onset of the fatal mucosal disease ([@evx046-B40]; [@evx046-B10]). The existence of cp and ncp biotypes together with the availability of reverse genetics ([@evx046-B40]; [@evx046-B42]) and a cell culture based RNA recombination system ([@evx046-B20]; [@evx046-B3]) makes BVDV a particularly suited model to study fundamental aspects of RNA recombination. In the BVDV system, RNA recombination is monitored by the detection of newly emerged replicating viral RNA genomes that are amplified by the viral RdRp. Accordingly, the experimental design applied in the present study excludes the detection of artificial recombination events resulting from template-switching during RT-PCR driven amplification of RNA molecules. Although it has been demonstrated that viral RNA recombination can occur in the absence of a functional RdRp ([@evx046-B20]), the role of other viral proteins for RNA recombination has not been investigated so far. The present study proves that efficient translation of pestiviral proteins is not required for frequent nonreplicative RNA recombination in cell culture. Moreover, characterization of selected recombinant viruses demonstrates a remarkable flexibility with regard to the structure of C protein.

Materials and Methods
=====================

Cells
-----

Madin-Darby bovine kidney (MDBK) cells were obtained from the American Tissue Culture Collection (Manassas, VA). MDBK cells were grown in Dulbecco's modified Eagle's (EDulb) medium supplemented with 5% horse serum. Baby hamster kidney (BHK-21) cells were obtained from the DSMZ (Braunschweig, Germany) and maintained in EDulb medium supplemented with 5% fetal calf serum.

Construction of BVDV cDNA Clones
--------------------------------

All recombination partners are based on the parental construct plasmid pCP7-388, which displays a cDNA copy of the complete genome of the BVDV-1 strain CP7 under the control of an SP6 RNA polymerase promoter ([@evx046-B42]). The nucleotide numbering included in this study refers to the published full-length genomic sequence of CP7-388 encompassing 12293 nucleotides ([@evx046-B42]). The plasmids encoding 5′ recombination partners CP7/1-686 (pCP7/1-686) and CP7/1-997 (pCP7/1-997) comprise the 5′ terminal 686 and 997 nucleotides of the BVDV CP7 genome downstream of an SP6 promoter, respectively. The plasmid encoding the 3′ recombination partner Ubi-CP7/887-12293 (pUbi-CP7/887-12293) contains a T7 promoter directly upstream of nucleotides 1-513 of p + ubi-SGT ([@evx046-B20]), coding for five C-terminal amino acids (aa) of the NS2 gene of BVDV strain CP14 and a C-terminal fragment, as well as two complete ubiquitin monomers, followed by nucleotides 887-12293 of pCP7-388. This genomic region encodes the entire C protein, the three envelope proteins, and (with the exception of N^pro^) all nonstructural proteins and also comprises the complete 3′NTR. Plasmids pCP7/1-686, pCP7/1-997, and pUbi-CP7/887-12293 were cloned by standard cloning procedures. For construction of the 3′ recombination partner NLuc-Ubi-CP7/887-12293, a plasmid containing a NheI-site that is followed by a T7 promoter sequence, a noncoding sequence of 21 nucleotides (GCATCCCTGAGACAAGCCACC), the Nano-luciferase (NanoLuc) coding sequence, the porcine teschovirus-1 2A peptide encoding sequence (allowing efficient processing at the C-terminus of the 2A peptide ([@evx046-B32])), and two complete ubiquitin monomers, followed by nucleotides 887-1916 of pCP7-388 was synthesized (Genscript), and further digested with NheI and HindIII in order to replace the corresponding region of plasmid pUbi-CP7/887-12293.

To analyze the processing of the C-ubi-C fusion proteins of recombinants R-2 and R-3, plasmids encoding the N-terminal part of N^pro^ to the C-terminal part of C of R-2 and R-3 were constructed (pCITE_P-2 and pCITE_P-3) by standard cloning procedures ([fig. 3*C*](#evx046-F3){ref-type="fig"}). The N^pro^ and C coding sequence of R-1 served as control (pCITE_P-1). Plasmids pCITE_P-2 and pCITE_P-3 served as template for site-directed mutagenesis using phosphorylated primers in order to exchange the first amino acid of the full length C protein from a serine into a proline residue (aa 250 for R-2, aa 257 for R-3). The PCR products were excised from a 1% agarose-gel, purified, and subsequently self-ligated with T4 DNA ligase (NEB) resulting in plasmids pCITE_P-2P and pCITE_P-3P.F[ig]{.smallcaps}. 3.---Schematic representation and expression of the N-terminal part of the viral polyprotein encoded by selected emerged recombinants. (*A*) Illustration of the N^pro^ and C protein region of recombinant viruses R-1 (corresponding to wt virus), R-2, R-3, R-4, R-5, and R-6. R-4 and R-5 emerged after cotransfection with CP7/1-686 and Ubi-CP7/887-12293, the four remaining recombinants derived from experiments with CP7/1-997 and Ubi-CP7/887-12293. Numbers below boxes indicate the presence of complete and partial proteins encoded by the recombinant viruses and refer to the authentic proteins encoded by wt virus (N^pro^: 168 aa, C protein: 90 aa) or a cellular ubiquitin monomer (consisting of 76 aa). The asterisks mark the positions of encoded amino acids differences of the recombinant genomes compared with the recombination partners. For R-2 four nucleotides at the junction site are identical to both recombination partners, and therefore, the recombination site could not be determined precisely. The black arrows indicate cleavage by the autoprotease N^pro^ (R-1, R-2, and R-3). The putative cleavage site (cleavage mediated by cellular ubiquitin C-terminal hydrolase) within the C-ubi-C fusion proteins encoded by recombinants R-2 and R-3 is indicated by white arrows. (*B* and *C*) Detection of N^pro^ and C protein in cell lysates of infected MDBK cells by Western blot analysis. Cells were infected at an MOI of 0.01 with the indicated recombinant viruses. Noninfected cells (−) served as negative control. N^pro^ and N^pro^ fusion proteins as well as C and C fusion proteins were detected 48 h p.i. with the N^pro^-specific monoclonal antibody 13B6 (*B*) and the C-specific monoclonal antibody 1F7 (*C*), respectively. An unspecific cellular protein with an apparent molecular weight of about 25 kDa, which was also detected in noninfected cells, was detected by the antibody 1F7.

All plasmids described in this chapter were tested by restriction enzyme mapping and the sequences of these plasmids were confirmed by nucleotide sequence analysis. Further details of the cloning strategies can be obtained from the authors upon request.

Synthesis of RNA Fragments
--------------------------

*In vitro* transcription of recombination partners and electroporation of RNA was performed as described previously ([@evx046-B20]; [@evx046-B3]). Briefly, cDNA was transcribed into RNA using SP6- or T7-Megascript kit (Ambion) depending on the promoter of the respective plasmid. After TurboDNase (Ambion) digestion for 15 min at 37 °C, the RNA was extracted with Megaclear kit (Ambion) according to the manufacturer's instructions. Concentrations of RNA were photometrically determined with NanoDrop (Thermo Scientific) and the quality of RNA was controlled by ethidium bromide staining of samples after agarose gel electrophoresis.

Electroporation, Detection of Recombinant Viruses, and Virus Rescue
-------------------------------------------------------------------

The recombination partners were electroporated (180 V, 950 µF) with a GenePulser Xcell (Bio-Rad) ([@evx046-B8]) in a molar ratio of 5:1, namely 2 pmol of the 3′ recombination partner and 10 pmol of one of the 5′ recombination partners, into MDBK cells. Ten percent of the electroporated cells were subjected to a 10-fold dilution in a suspension of naïve cells. The undiluted electroporated cells as well as the diluted cells were distributed to 48 wells of two 24-well plates after electroporation. From day 3 to day 5 postelectroporation (p.e.) the cells were checked daily for cytopathic effect (CPE) by light microscopic inspection. The supernatants of each well were collected and after treatment with trypsin, the cells of each well were transferred separately to a well of a six-well plate and checked for CPE after an additional incubation time of 20--48 h. The cells were either harvested for RNA extraction or heat fixated for the detection of BVDV antigen by indirect immunofluorescence (IF) analysis with anti-NS3 monoclonal antibody BVD/C16 (diluted 1:25 in PBS with 0.02% Tween 20 \[PBS-Tween\]) ([@evx046-B44]) and Cy3-conjugated goat antimouse IgG (diluted 1:800 in PBS-Tween; Dianova). The 10-fold diluted electroporated cells were directly heat fixated 5 days p.e. and analyzed by IF. For first virus passage, 5 × 10^5^ MDBK cells were infected with 500 µl of the collected supernatants of the recombinant viruses. Three to four days later, 1 ml tissue culture supernatant was used to infect 3 × 10^6^ MDBK cells for further virus passages. This procedure was repeated and the virus titers were determined as 50% tissue culture infectious doses (TCID~50~) per ml as described previously ([@evx046-B42]). Depending of the reached titers, the second or third passage of the recombinant viruses was used for the experiments described in this study.

Analysis of Recombinant Genomes
-------------------------------

Total cellular RNA was prepared using the RNeasy Mini kit (Qiagen). The cDNA synthesis and subsequent PCR (applying 2 μl cDNA) were performed as described previously ([@evx046-B46]). Cycling conditions were as follows: 98 °C, 30 s; 35 × (98 °C, 15 s; 58 °C, 30 s; 72 °C, 35 s); 72 °C, 5 min; 4 °C. For PCR amplification of the 5′-terminal part of the recombinant viral genomes BVDV specific oligonucleotides Ol-1400R (nucleotides 1427--1445; antisense primer) and Ol-100 (nucleotides 105--125; sense primer) were used ([@evx046-B6], [@evx046-B7]). For amplification of the NS3 gene, 2 μl cDNA each were subjected to two PCRs with primer pairs Ol_CP7_5133F (nucleotides 5133 to 5153; sense primer) and Ol_CP7_6137R (nucleotides 6137--6156; antisense primer) and Ol_CP7_6025F (nucleotides 6025--6045, sense primer) and Ol_CP7_7328R (nucleotides 7328--7348; antisense primer), respectively, using the Maxima Hot Start Green PCR Master Mix (Thermo Scientific) according to the manufacturer's instructions.

Nucleotide sequencing was carried out by commercial sequencing services (Qiagen or LGC). The obtained sequences were analyzed by using the GCG software package included in HUSAR (DKFZ, Heidelberg, Germany) ([@evx046-B19]). In addition, the N^pro^ and C coding sequences of the recombinant viruses were confirmed by sequence analysis at the end of the experiments used for determination of viral growth kinetics and viral RNA synthesis.

Transient Protein Expression
----------------------------

For transient expression of recombinant proteins, the MVA-T7 system was applied as previously described ([@evx046-B39]). Briefly, BHK-21 cells (7.5 × 10^5^) were infected with recombinant MVA-T7 virus and 2 h later transfected with the respective plasmid (pCITE_P-1, pCITE_P-2, pCITE_P-2P, pCITE_P-3, pCITE_P-3P) using Lipofectamine 2000 (Thermo Fisher Scientific). Recombinant MVA-T7 virus was kindly provided by Gerd Sutter (Ludwig-Maximilians-Universität München, Munich, Germany). Twenty hours posttransfection the cells were lysed using NP40 lysis buffer (50 mM Tris/HCl \[pH 7.5\], 150 mM NaCl, 0.5% \[w/v\] sodium deoxycholate, 1% \[v/v\] NP-40, complete protease inhibitor \[Roche\]). Protein concentration was determined by using the BCA protein assay kit (Pierce Biotechnologies).

SDS-Page and Western Blotting
-----------------------------

Cells were lysed using NP40 lysis buffer and proteins were separated in 12% or 15% polyacrylamide gels. After sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) proteins were transferred to nitrocellulose membrane or PVDF membrane. The membrane was blocked with 2% ECL Blocking Buffer (GE Healthcare Bio-Sciences AB). For detection of N^pro^ and C the mouse monoclonal antibodies (MAb) 13B6 and 1F7 were used, both diluted 1:5 in PBS containing 0.02% Tween 20 (PBS-Tween), respectively. Both antibodies were generated according to standard procedures previously described ([@evx046-B34]). Antibody binding was detected by using a secondary rabbit anti-mouse peroxidase-coupled antibody diluted 1:1000 in PBS-Tween (Dako) and ECL Advanced Western Blotting Detection kit or ECL Select Western Blotting Detection kit (GE Healthcare Bio-Sciences AB).

Determination of Growth Kinetics
--------------------------------

MDBK cells (1 × 10^6^) were infected in a six-well dish with infectious supernatants of the recombinant viruses R-1, R-2, R-3, R-4, and R-5 at a multiplicity of infection (MOI) of 0.01. After adsorption for 1 h at 37 °C, the cells were washed six times with PBS, overlaid with medium containing 5% horse serum, and incubated at 37 °C and 5% CO~2~. At 0, 6, 12, 24, 36, 48, 72, and 96 h postinfection (p.i.) aliquots (230 µl) of the supernatant were removed and replaced by fresh medium. The supernatants of three independent experiments were used individually for titration on MDBK cells. After 72 h incubation at 37 °C, virus detection was carried out by NS3-specific IF analysis as described above. Titers were determined as 50% tissue culture infectious doses (TCID~50~) per ml as described previously ([@evx046-B42])

Quantification of Viral RNAs by Real-Time RT-PCR
------------------------------------------------

Real-time RT-PCR was performed in a qPCR system Mx3005P apparatus (Agilent). For comparative analysis of the quantities of accumulated viral RNA genomes, MDBK cells (1 × 10^6^) were infected with supernatants of the recombinant viruses R-1, R-2, R-3, R-4, and R-5 at an MOI of 0.01. Total cellular RNA was prepared 10 h p.i., marking the end of one replication cycle ([@evx046-B25]). Total cellular RNA from three independent experiments was prepared using the RNeasy Mini kit (Qiagen). The RNA was diluted in a ratio of 1:50 in RNA-safe buffer (50 ng/μl poly\[A\] carrier RNA, 0.05% Tween 20, and 0.05% sodium azide in nuclease-free water). For comparative quantification of viral RNA, 5 µl of the diluted RNAs as well as five serial 10-fold dilutions of a BVDV RNA standard and a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) standard were subjected to a one-step duplex real-time RT-PCR (qRT-PCR) using the QuantiTect Probe PCR kit (Qiagen). BVDV genome load and GAPDH mRNA abundance were simultaneously detected in the same reaction tube in triplicates. For amplification of BVDV genomes the primer pair Pesti.100F (5′-CTAACCATGCCCTTAGTAG-3′) and Pesti.206R (5′-CGTCGAACCACTGACGACT-3′), and the probe BVDV.139p (5′-*FAM*-TAGCAACAGTGGCGAGTTCGTTGGATGGCT-*BHQ1*-3′), which were adapted from a previous publication ([@evx046-B5]) and target the 5′NTR, were used. For amplification of the GAPDH mRNA, the primers GAPDH.465F (5′-GGCGTGAACCACGAGAAGTATAA-3′) and GAPDH.583R (5′-CCCTCCACGATGCCAAAGT-3′), and the probe GAPDH.490p (5′-*HEX*-ACACCCTCAAGATTGTCAGCAATGCCTCCT-*BHQ1*-3′), which were adapted from a previous publication ([@evx046-B36]), were used. Cycling conditions were as follows: 50 °C, 30 min; 95 °C, 15 min; 40 × (95 °C, 30 s; 60 °C, 30 s; 72 °C, 30 s). The quantity of viral RNA was normalized to the abundance of bovine GAPDH mRNA. For comparing the viral RNA quantities of the recombinant viruses R-1, R-2, R-3, R-4, and R-5 in cells 10 h p.i., the viral RNA amount of R-1 was set 100%.

Determination of Translational Activity of the 3′ Recombination Partner
-----------------------------------------------------------------------

For the luciferase reporter assay, a portion of the electroporated cells used for the RNA recombination experiments and detection of recombinant viruses was seeded in quadruplicates into 96-well plates (4 × 10^4^ cells per well). Four hours p.e. the cells were washed with PBS, overlaid with 50 µl PBS and expression of luciferase was measured with the Nano-Glo Luciferase Assay System (Promega) according to the manufacturer's instructions in a Genios Pro chemiluminometer (Tecan).

Statistical Methods
-------------------

Statistical analysis was performed using the *t*-test. Significance was considered with *P* values \<0.05. Statistical tests were run using the freeware program R.

Results
=======

Experimental Design and Structure of Recombination Partners
-----------------------------------------------------------

In order to determine if translation of viral proteins is essential for RNA recombination, a recombination system based on cotransfection of cells with two synthetic replication-incompetent RNA genome fragments (5′ and 3′ recombination partner) derived from cp BVDV strain CP7 was established ([fig. 1*A* and *B*](#evx046-F1){ref-type="fig"}). The two constructed 5′ recombination partners ([fig. 1*B*](#evx046-F1){ref-type="fig"}) comprise the complete 5′NTR including the IRES element essential for pestiviral translation plus a short part of the N^pro^ coding region (5′ recombination partner CP7/1-686) or the genomic region encoding the complete N^pro^ and part of C protein (5′ recombination partner CP7/1-997). Accordingly, both 5′ recombination partners lack major parts of the entire polyprotein coding region and the 3′NTR and thus are replication incompetent. The 3′ recombination partner Ubi-CP7/887-12293 represents a 5′ truncated BVDV genome, lacking the 5′NTR with the IRES element and the N^pro^ coding region ([fig. 1*B*](#evx046-F1){ref-type="fig"}). This partner encompasses the entire genetic information for all other viral structural and nonstructural proteins and also includes the complete 3′NTR, which is essential for viral replication ([@evx046-B42]). At the 5′ end of this construct, an additional sequence derived from BVDV strain CP14 ([@evx046-B20]), which encodes five C-terminal amino acids of NS2, a C-terminal ubiquitin fragment (14 aa), as well as two complete ubiquitin monomers (76 aa each), was included. The ubiquitin coding sequence was introduced into the 3′ partner in order to facilitate appropriate processing of the N-terminus of the downstream located C protein in putatively generated recombinants. As the 3′ recombination partner lacks the IRES element, IRES-mediated translation of this viral RNA fragment cannot occur. Several independently performed experiments demonstrated that transfection of MDBK cells with the individual recombination partners did not result in translation of detectable amounts of viral protein NS3 and did not produce replicating viruses (data not shown).F[ig]{.smallcaps}. 1.---Structure of BVDV recombination partners. (*A*) Genome organization of BVDV strain CP7, which represents the genetic basis of the recombination partners used in this study (details are described in the introduction). (*B*) Schematic representation of the 5′ and 3′ recombination partners applied for RNA recombination experiments. The two depicted 5′ recombination partners comprise a complete 5′ NTR (nt 1-382) with the IRES element and either nt 383-686 encoding an N-terminal part of N^pro^ (CP7/1-686) or nt 383-997 encoding the complete N^pro^ and a short N-terminal part of C (CP7/1-997). The 3′ recombination partner Ubi-CP7/887-12293 contains a fragment derived from BVDV strain CP14, which encodes the five C-terminal aa of NS2, the C-terminal 14 aa of ubiquitin as well as two complete ubiquitin monomers (76 aa each), fused to a long sequence fragment corresponding to nt 887-12293 of BVDV CP7 wt virus. Nucleotide numbering refers to the genomic sequence of CP7-388 ([@evx046-B42]).

Emergence of Recombinant Viruses in the Absence of IRES-Mediated Translation of Viral Proteins
----------------------------------------------------------------------------------------------

After cotransfection of cells with 2 pmol of the 3′ recombination partner and 10 pmol of either 5′ recombination partner CP7/1-686 or partner CP7/1-997, recombinant viruses emerged and were detectable by their cytopathic effect on cell culture. In three cotransfection experiments with each 5′ partner a total of at least 70 independently emerged recombinant viruses were recovered and subsequently analyzed by RT-PCR and nucleotide sequencing. For 58 recombinant genomes (29 from each 5′ recombination partner), the sequences corresponding to nucleotide positions 126--1426 of the BVDV CP7 genome were analyzed for determination of the recombination sites. For the remaining 12 virus-positive RNAs, limited amounts of the obtained PCR products did not allow determination of nucleotide sequences. The emergence of recombinant viruses after cotransfection of MDBK cells with two BVDV RNA fragments either lacking almost the complete genomic region encoding the viral proteins (5′ partner) or the IRES element (3′ partner) demonstrates that RNA recombination can occur in the absence of IRES-mediated translation of viral proteins.

Genome Structure of the Recombinant Viruses
-------------------------------------------

Analyses of the cross-over sites of 58 recombinant viruses revealed, that with the exception of one homologous recombinant (R-1) all other viruses emerged by nonhomologous RNA recombination, which occurred exclusively at internal positions of the recombining RNA molecules ([fig. 2*A* and *B*](#evx046-F2){ref-type="fig"}). Further analysis of the recombination sites did not provide evidence for a sequence bias. The distribution of nucleotides and dinucleotides situated at the recombination sites resembles the distribution of dinucleotides in the particular genome stretches. The extent of nucleotide identity between the recombining RNA molecules at the cross-over site was not significantly higher than the expected random level. The recombination sites in both 5′ partners were exclusively located within the coding regions, which was in line with the requirement of a complete 5′NTR for preserving a functional IRES element. Although the recombination sites in the 3′ recombination partner were predominantly located in the ubiquitin coding region (47 of 58 recombinants), for eleven recombinants the 3′ recombination sites were located within the C coding region. Furthermore, 20 analyzed recombinant genomes did not encode for a complete ubiquitin monomer. As it was previously shown that an incomplete ubiquitin monomer leads to abrogation of processing by cellular proteases ([@evx046-B56]), it was assumed that the respective recombinant viruses (e.g., R-2 and R-3) express C fusion proteins of up to 178 aa instead of the authentic C protein consisting of 90 aa ([fig. 3*A*](#evx046-F3){ref-type="fig"}). These proteins would comprise C-terminal parts of either N^pro^ or C protein fused to an N-terminally truncated ubiquitin followed by a complete C protein (N^pro^-ubi-C and C-ubi-C fusion proteins \[[figs. 3 and 4](#evx046-F3 evx046-F4){ref-type="fig"}\]). Accordingly, duplications of C protein-coding sequences of up to 109 nucleotides (R-3) were found in recombinant genomes. Furthermore, other recombinant virus genomes encode for N^pro^-C fusion proteins (e.g., R-4, R-5, and R-6). Their size varied from 89 aa (R-4) to 195 aa (R-6), which was the largest putative fusion protein predicted for the analyzed recombinant viruses ([fig. 3*A*](#evx046-F3){ref-type="fig"}).F[ig]{.smallcaps}. 2.---Recombination sites within the 5′ recombination partners and the 3′ recombination partner. The cross-over sites for 29 independently emerged recombinants, derived from cotransfection experiments with the 3′ partner and either with the 5′ recombination partner CP7/1-686 (*A*) or CP7/1-997 (*B*) are schematically displayed by lines between the bars. N^pro^ coding sequences are highlighted in red, ubiquitin coding sequences in blue and C protein coding sequences in yellow. For the 3′ recombination partner, the genomic region encoding proteins E^rns^ to NS5B is indicated by dots. Bottom: One homologous recombinant (R-1). The two vertical lines between the recombination partners indicate the genomic region in which the cross-over site is located.F[ig]{.smallcaps}. 4.---Processing of fusion proteins of recombinants R-1, R-2, and R-3. (*A*) Schematic representation of authentic (P-1, P-2, P-3) and mutated (P-2P, P-3P) fusion proteins transiently expressed in the MVA-T7 system. P-1 encompasses the wt proteins N^pro^ and C, P-2 and P-3 comprise N^pro^ and the C fusion proteins encoded by the recombinant viruses R-2 and R-3, respectively. In P-2P and P-3P, the asterisks mark the serine to proline substitutions directly downstream of the ubiquitin fragments. Black arrows indicate autoproteolytic cleavage mediated by N^pro^. White arrows (P-2 and P-3) indicate partial processing directly downstream of the ubiquitin fragments. (*B* and *C*) Western blot analysis. BHK-21 cells were infected with MVA-T7 and transfected with pCITE-N^pro^-C constructs encoding P-1, P-2, P-2P, P-3, and P-3P, respectively. Nontransfected cells (−) served as negative control. Cells were lysed 20 h posttransfection and analyzed by Western blot using MAb 1F7 (panel *B*) and MAb 13B6 (panel *C*) to detect C (C-ubi-C) and N^pro^, respectively.

Six representative recombinant viruses (R-1 to R-6) were selected ([fig. 3*A*](#evx046-F3){ref-type="fig"}) and subjected to further analyses with regard to protein expression, growth kinetics, and viral RNA synthesis. Virus propagation up to passage 12 and subsequent RT-PCR analyses of RNA obtained after passage 2, 5, 9, and 12 revealed an unaltered size of amplified PCR products (5′ NTR, N^pro^, and C coding region) for each of the individual recombinants (R-1 to R-6) over time (data not shown).

Expression of N^pro^ and C
--------------------------

In order to determine if the detected genome alterations of the selected recombinants R-1 to R-6 correlated with expression of the predicted fusion proteins, Western blot analysis was performed. In terms of N^pro^ expression, a protein with the expected apparent molecular weight of 20 kDa was detected for the homologous recombinant R-1 (corresponding to BVDV CP7 wild-type \[wt\] virus) as well as for the nonhomologous recombinants R-2 and R-3 ([fig. 3*B*](#evx046-F3){ref-type="fig"}). For recombinant virus R-4, an N^pro^-specific protein was not detectable as it probably did not display the respective epitope due to its shortened sequence. For recombinants R-5 and R-6 Western blot analysis revealed significantly enlarged proteins with a molecular weight of ∼25 kDa corresponding to the length of the predicted N^pro^-C fusion proteins.

Regarding the expression of C protein, a specific protein with the size of approximately 14 kDa was detected by Western blot analysis for recombinant R-1 ([fig. 3*C*](#evx046-F3){ref-type="fig"}). For R-4 a protein with a slightly lower molecular weight was detected and thus confirmed the predicted shorter fusion protein of 89 aa. The fusion proteins' sizes of recombinants R-2, R-3, and R-5 corresponded to the predicted lengths of about 25 kDa. Also for recombinant R-6 an enlarged fusion protein of about 25 kDa was detected, though merely a weak band was visible. The size of the detected fusion protein corresponds to that detected in the N^pro^ blot. Surprisingly, for R-2 and R-3 an additional protein comigrating with mature C protein was detected. This finding can be explained by a hypothetical processing event downstream of the incomplete ubiquitin monomer mediated by cellular ubiquitin carboxy-terminal hydrolases (UCH), although this processing appeared to be inefficient.

To confirm this hypothesis, the C-ubi-C fusion proteins of R-2 and R-3 and derivates of these fusion proteins with a serine to proline mutation directly downstream of the N-terminally truncated ubiquitin were transiently expressed using the MVA-T7 system ([fig. 4*A*](#evx046-F4){ref-type="fig"}). It has been described that the presence of a proline residue at this position inhibits UCH cleavage ([@evx046-B14]). Comparative analysis of the recombinant C-ubi-C fusion proteins of R-2 and R-3 with or without proline substitution revealed that the fusion proteins containing the serine residue were partially cleaved, whereas no cleavage occurred if the serine residue was replaced by a proline residue ([fig. 4*B*](#evx046-F4){ref-type="fig"}). Processed C and C-ubi-C fusion proteins were detected at the same molecular weights as previously observed after infection of permissive cells with the recombinant viruses. However, the relative amount of processed C was lower after transient expression ([fig. 4*B*](#evx046-F4){ref-type="fig"}). This might be due to differences in protein expression after infection of bovine MDBK cells with recombinant virus and transient expression using the MVA-T7 system in BHK-21 cells or due to the different time points of the analysis (48 vs. 20 h, respectively). The detected amounts of N^pro^ protein confirmed similar transient expression levels for each construct ([fig. 4*C*](#evx046-F4){ref-type="fig"}).

Growth Characteristics and RNA Synthesis of Recombinant Viruses
---------------------------------------------------------------

Growth characteristics and RNA synthesis of the selected recombinant viruses were compared by infection of MDBK cells at an MOI of 0.01 ([fig. 5*A* and *B*](#evx046-F5){ref-type="fig"}). R-6 had a very low replication rate resulting in maximum titers of about 7 × 10^3^ TCID~50~/ml. Therefore, it was not possible to obtain sufficient amounts of virus to include R-6 in the analysis of viral growth characteristics and RNA synthesis. Virus titers were analyzed at different time points (0 to 96 h p.i.). For recombinants R-2 and R-3, the obtained growth curves and maximum virus yields were comparable to recombinant R-1 ([fig. 5*A*](#evx046-F5){ref-type="fig"}). In contrast, for R-4 and R-5 a significant decrease in viral titers was observed 36 h p.i. Regarding the maximum titers reached by recombinants R-4 (2.8 × 10^5^ TCID~50~/ml) and R-5 (1.1 × 10^5^ TCID~50~/ml), a reduction of about 5-fold (R-4) and about 14-fold (R-5) compared with R-1 (1.5 × 10^6^ TCID~50~/ml) was detected. For analysis of viral RNA production, total cellular RNA was prepared at 10 h p.i. to exclude the effects of potential differences in viral spread, as this time point correlates with the end of the first viral replication cycle ([@evx046-B25]). The relative amounts of accumulated viral RNA were determined by quantitative real-time RT-PCR and normalized to the abundance of GAPDH RNA ([fig. 5*B*](#evx046-F5){ref-type="fig"}). Compared with the amount of RNA accumulated in cells infected with R-1, the RNA amount detected for recombinants R-2 and R-3 was slightly reduced (2-fold and 1.5-fold, respectively). Although the mean value of R-5 was reduced by 1.7-fold, no significant difference in terms of viral RNA level was detected for R-4 and R-5 compared with R-1.F[ig]{.smallcaps}. 5.---Infectious virus production and RNA synthesis of selected recombinant viruses. MDBK cells were infected with the recombinant viruses R-1, R-2, R-3, R-4, and R-5 at an MOI of 0.01. (*A*) Growth kinetics of the recombinant viruses. Viral titers were determined over a 4-day period. Depicted are mean values and standard deviations of three independent experiments. (*B*) Relative amounts of accumulated viral genomic RNA. Total cellular RNA was prepared 10 h p.i. and subjected to quantitative real-time RT-PCR. The viral RNA amounts were normalized to the abundance of GAPDH RNA. The data were plotted relatively to R-1, which corresponds to the wt virus, and the amount of viral RNA of R-1 was set as 100%. Data show the mean values and standard deviations of three independent experiments, each analyzed in triplicate. The asterisks mark a significant reduction in viral RNA level compared with R-1.

It was previously shown that efficient replication of CSFVs, with massively enlarged or almost completely deleted C proteins, depends on single amino acid substitutions within the NS3 gene ([@evx046-B48], [@evx046-B47]). Therefore, the NS3 genes of the six analyzed recombinant viruses were amplified by RT-PCR and subsequently sequenced. Except from R-3, which revealed a single amino acid exchange from valine to alanine at position 2278 (position within CP7 strain), no adaptive mutations were identified. Considering that the replication of R-4, R-5, and R-6 is reduced, it appears likely that these recombinant viruses undergo further evolution to increase their replication efficiencies if passaged sufficiently. Additional passages of these recombinant viruses were not performed so far as a further detailed analysis of the genetic stability and evolution of these viruses was not within the scope of this study.

Efficient Translation of Viral Proteins Does Not Enhance Nonreplicative RNA Recombination
-----------------------------------------------------------------------------------------

The results of the RNA recombination experiments described above demonstrated that IRES-mediated translation of viral proteins is not required for RNA recombination ([figs. 1 and 2](#evx046-F1 evx046-F2){ref-type="fig"}). However, it cannot be excluded that low level of IRES-independent translation of viral proteins occurred and contributed to RNA recombination. Therefore an additional set of RNA recombination experiments including quantification of translation efficiency was performed. To allow quantification of translation of the 3′ recombination partner, a luciferase reporter gene was introduced into the 3′ recombination partner at its 5′ terminus (termed NLuc-Ubi-CP7/887-12293) ([fig. 6*A*](#evx046-F6){ref-type="fig"}). For efficient translation of viral proteins, the 3′ recombination partner NLuc-Ubi-CP7/887-12293 was capped prior electroporation. After cotransfection of MDBK cells with the 5′ recombination partner CP7/1-997 (10 pmol) and either a capped or uncapped 3′ recombination partner NLuc-Ubi-CP7/887-12293 (2 pmol each), the number of emerged recombinant viruses was determined for each set-up in three independent experiments ([fig. 6*A*](#evx046-F6){ref-type="fig"}). In parallel, a portion of the (co)transfected cells was subjected to a luciferase reporter assay 4 h p.e. for quantitative detection of translation ([fig. 6*B*](#evx046-F6){ref-type="fig"}). Luciferase reporter assay analysis demonstrated that capping of the 3′ recombination partner resulted in a 200- to 600-fold increase of translation compared with the uncapped 3′ recombination partner ([fig. 6*B*](#evx046-F6){ref-type="fig"}).F[ig]{.smallcaps}. 6.---Efficient translation of viral proteins does not enhance nonreplicative RNA recombination. (*A*) Schematic representation of the applied 5′ and 3′ recombination partners. The 5′ recombination partner CP7/1-997 (5′ partner) has been described in figure 1. The 3′ recombination partner NLuc-Ubi-CP7/887-12293 (3′ partner) is a modified version of the 3′ recombination partner Ubi-CP7/887-12293 (see fig. 1) with a replacement of the 5′-terminal sequence coding the C-terminal 14 aa of ubiquitin by a luciferase reporter gene and the coding sequence for the porcine teschovirus-1 2A peptide. Nucleotide numbering refers to the positions in the genome of the wt virus. (*B*) Luciferase activity. Absolute values of luciferase activity measured 4 h p.e. of the 3′ partner (capped and uncapped) alone or in combination with the 5′ partner. Reaction set-ups with the 3′ recombination partner Ubi-CP7/887-12293 (without luciferase reporter gene) and nontransfected cells (−) served as control. Data show the mean values and standard deviations of one of three independent experiments. (*C*) Number of recombinant viruses emerged after cotransfection of cells with the 5′ recombination partner CP7/1-997 and the capped or uncapped 3′ recombination partner NLuc-Ubi-CP7/887-12293. Data of three independent experiments are shown.

Three independent cotransfection experiments revealed that capping and subsequent enhanced translation of viral proteins encoded by the 3′ recombination partner did not result in an increased RNA recombination frequency ([fig. 6*C*](#evx046-F6){ref-type="fig"}). In more detail, 28 recombinants emerged after cotransfection with the capped template compared with 65 recombinants produced in the three control experiments with the uncapped template. The reason for the observed slight decrease in the yield of recombinants produced with the capped template remains elusive. One possible explanation is that the capping reaction might have a negative effect on the integrity of the RNA. Alternatively, it can be speculated that ribosomal binding of the capped RNA template might limit its accessibility for nonreplicative joining of RNA molecules Nine independently emerged recombinant viruses were analyzed regarding their cross-over sites, which were comparable to those of the recombinant viruses shown in [figure 2](#evx046-F2){ref-type="fig"} (data not shown). Taken together, the results of the present study demonstrate that nonreplicative RNA recombination can occur in the absence of IRES mediated translation of pestiviral proteins and is not enhanced by efficient translation of viral proteins ([fig. 6](#evx046-F6){ref-type="fig"}).

Discussion
==========

Nonreplicative RNA recombination has been proven for several plus-strand RNA viruses including poliovirus, BVDV, and HCV ([@evx046-B24]; [@evx046-B20]; [@evx046-B49]). Although it has previously been shown that RNA recombination in pestiviruses can occur in the absence of a functional RNA-dependent RNA polymerase (RdRp), the role of other viral proteins remained unclear ([@evx046-B20]). Several pestiviral proteins (C, E^rns^, NS3, NS4B, and NS5B) were shown to interact with the viral RNA ([@evx046-B62]; [@evx046-B27]; [@evx046-B28]; [@evx046-B41]; [@evx046-B22]). It was therefore interesting to investigate whether viral proteins other than the RdRp are involved in RNA recombination. By the detection of over 70 independently emerged recombinant viruses the results of the present study demonstrate that IRES-mediated translation of the pestiviral proteins is not required for nonreplicative RNA recombination. Moreover, our conclusion that RNA recombination can occur independent from translation of viral proteins is further supported by the observation that increasing the efficiency of translation of viral proteins by capping of the 3′ recombination partner (carrying an almost complete polyprotein encoding sequence) did not enhance RNA recombination ([fig. 6](#evx046-F6){ref-type="fig"}).

With regard to the recombination system applied in this study, one might argue that the possibility of noncanonical initiation of translation might result in the expression of small amounts of viral proteins and a small background RNA-dependent RNA polymerase (RdRp) activity in the very early stages of transfection might lead to replication-driven recombination. A strong argument against such a scenario of a possible early RdRp activity in the experiments described in the present study is provided by the results of previously reported experiments. Two independent studies in the poliovirus and BVDV system have demonstrated that transfection of cells with two synthetic overlapping subgenomic transcripts each lacking a functional RdRp gene resulted in the generation of recombinant RNA genomes and thereby proved the existence of nonreplicative recombination in the absence of a viral RdRp ([@evx046-B20]; [@evx046-B24]). The recombination system applied in the present study is very similar to the one used for the proof of nonreplicative RNA recombination ([@evx046-B20]) as both are based on cotransfection of cells with overlapping nonreplicative BVDV subgenomic transcripts resulting in the emergence of recombinant infectious viral RNA genomes. The similar number of recombinant viruses generated in the experiments of these two studies strongly suggests that RNA recombination in both systems results from nonreplicative RdRp-independent reactions.

Nonreplicative RNA recombination in the absence of translation of viral proteins was also suggested in a study with poliovirus genomic RNA fragments, in which the 5′ fragments carried the IRES element and a spacer sequence and each of the three 3′ fragments encompassed the complete authentic poliovirus coding sequence and 3′NTR as well as a modified 5′NTR with different lethal deletions and mutations in the essential *cis*-acting elements, resulting in abrogation of translation and replication activity ([@evx046-B23]). Similar to the results of the present study in the BVDV system, cotransfection of the poliovirus fragments led to the emergence of infectious virus progeny. In contrast to the results with BVDV and poliovirus RNA fragments, experiments with subgenomic transcripts derived from HCV, which did not allow translation of viral proteins prior to an RNA recombination event, did not result in the emergence of infectious virus progeny ([@evx046-B49]). This difference might be attributed to the fact that the first protein in the polyprotein of HCV, the C protein, is less tolerant for genomic changes than pestivirus N^pro^, which is dispensable for viral replication ([@evx046-B58]). The present study demonstrates that significantly enhanced translation of viral proteins did not increase the frequency of RNA recombination in BVDV, whereas the effect of enhanced translation of viral proteins on RNA recombination was not analyzed in the studies with poliovirus and HCV ([@evx046-B23]; [@evx046-B49]). In conclusion, the results of the present study in the BVDV system together with the previously reported results obtained with poliovirus RNA fragments show that nonreplicative RNA recombination does not require efficient translation of viral proteins.

Alternatively, it can be hypothesized that mechanisms involving cellular factors are implicated in nonreplicative RNA recombination leading to the emergence of recombinant viruses. It was previously proposed that the recombining RNA substrates might be provided by physical forces, cryptic ribozyme activity, or endoribonucleolytic cleavage ([@evx046-B17]; [@evx046-B24]; [@evx046-B20]). Furthermore, it was shown that modification of the 5′ triphosphate and 3′ hydroxyl ends of the recombining RNA molecules to 5′ hydroxyl and 3′ monophosphoryl ends resulted in a significantly increased RNA recombination frequency ([@evx046-B23]; [@evx046-B3]). RNA fragments with such RNA termini are typically produced by cellular endoribonucleases ([@evx046-B37]). The hypothesis of a ribonucleolytic involvement is underlined by the observed preferential occurrence of RNA recombination in single-stranded regions of the RNA substrates and by the fact that many endoribonucleases specifically cleave single-stranded RNA substrates ([@evx046-B37]; [@evx046-B3]). Indeed, cellular exo- and endoribonucleases were shown to influence the frequency of viral RNA recombination in plant and yeast cells ([@evx046-B51]; [@evx046-B16]; [@evx046-B30]; [@evx046-B29]). Therefore, ribonucleases might play an important role for BVDV RNA recombination. Although pestiviruses encode the unique viral endoribonuclease E^rns^ ([@evx046-B50]), the present study revealed that such a potential ribonucleolytic involvement must have derived from the host cell. Cellular components that are enriched with ribonucleases, like processing bodies (P-bodies) and stress granules (SG), were shown to be involved in viral life cycles of several RNA viruses ([@evx046-B12]). Thus, host ribonucleases may also be important for the intracellular generation of viral RNA templates that are similar to the ones described in the present study and may finally contribute to the emergence of viral recombinants during pestivirus infection. Further studies will address the role of cellular ribonucleases for providing the recombining RNA substrates. Another major goal of future studies on nonreplicative RNA recombination is the identification of the factors involved in the ligation reaction responsible for joining of the RNA fragments.

In the experiments described in the present study, high amounts of RNA were transfected which resulted in a low yield of recombinant viruses. Accordingly, it can be concluded that the translation-independent, nonreplicative process of RNA recombination is a rare event. For poliovirus, it has been reported that the frequency of replicative recombination is about 25-fold higher than the frequency of nonreplicative recombination ([@evx046-B38]). In the BVDV system, the frequencies of replicative and nonreplicative RNA recombination have not been compared so far. Under natural conditions, viral RNA genomes present in an infected cell cannot serve as substrates for nonreplicative recombination and subgenomic RNA molecules contributing to nonreplicative joining of RNA molecules have first to be generated, e.g., by ribonucleolytic cleavage as mentioned above. This may represent a significant limitation of the efficiency of nonreplicative RNA recombination. Nevertheless, if such an inefficient process results in the generation of infectious recombinant viruses with novel biological features, the biological consequences of nonreplicative RNA recombination might be dramatic. The emergence of cytopathogenic BVDV by RNA recombination in persistently infected cattle finally leads to lethal mucosal disease and thus represents an illustrative example of the biological significance of RNA recombination ([@evx046-B10]).

The analyzed recombinant viruses demonstrated a remarkable flexibility regarding the structure of the pestiviral C protein ([fig. 3*A*](#evx046-F3){ref-type="fig"}). Several emerged recombinant viruses express C-fusion proteins ranging from 89 to 195 aa instead of wt C protein consisting of 90 aa ([fig. 2*A* and *B*](#evx046-F2){ref-type="fig"}). The C protein is a structural viral protein, putatively involved in condensation of viral RNA and formation of the nucleocapsid ([@evx046-B28]; [@evx046-B41]). Evidence for the flexibility of C protein regarding increase and decrease of size has been described in the context of infectious cDNA clones of the related pestivirus CSFV ([@evx046-B48], [@evx046-B47]). In line with the results reported for CSFV C protein, the variety of differently sized BVDV C-fusion proteins described in this study stands in stark contrast to a rigid structure like an icosahedral nucleocapsid, as the described alterations presumably result in a highly different nucleocapsid shape. However, in contrast to the studies with CSFV ([@evx046-B48], [@evx046-B47]), no adaptive mutations within the NS3 gene were identified except one mutation in R-3 at aa position 2278. Regarding virus yield and RNA production, the results show that replacement of the C protein by enlarged N^pro^-C fusion proteins (R-4 and R-5) resulted in a substantial decrease in viral titers without significantly affecting viral RNA production ([fig. 5*A* and *B*](#evx046-F5){ref-type="fig"}). Also R-6, encoding an N^pro^-C fusion protein of more than twice the size of the parental C protein, reached only very low titers. It can be assumed that either the incorporation of large-scale fusion proteins into the virions or the lack of C protein in virions results in an altered structure of the virus particle, which is expected to influence virus assembly and entry, representing essential steps of the viral life cycle. Furthermore, also the uncoating of the viral RNA during the entry process might be impaired, resulting in reduced amounts of infectious virus progeny. In contrast, the genomic alterations of R-2 and R-3 only slightly affect viral RNA synthesis, which are negligible, as they have no relevant effect on efficient production of infectious viruses ([fig. 5*A* and *B*](#evx046-F5){ref-type="fig"}). It can be speculated that those recombinants have incorporated the unaltered C protein which was shown to be cleaved from C-ubi-C fusion proteins ([figs. 3*B* and 4*B*](#evx046-F3 evx046-F4){ref-type="fig"}), leading to the release of virions that presumably have the same shape as wt virus particles.

Several analyzed recombinant genomes encode truncated ubiquitin monomers, leading to the expression of large C-ubi-C fusion proteins with a length of up to 178 aa. According to the literature, one complete ubiquitin monomer is a prerequisite for N-terminal and C-terminal processing of the fusion proteins by cellular ubiquitin C-terminal hydrolases ([@evx046-B1]; [@evx046-B57]; [@evx046-B4]; [@evx046-B56]). Furthermore, it has been reported that the four N-terminal aa of a truncated ubiquitin can be functionally replaced by a host-derived oligopeptide for maintaining processing at the C-terminus of this ubiquitin fusion protein, whereas replacement by a randomly selected virus encoded peptide did not result in processing of the respective ubiquitin fusion protein ([@evx046-B9]). It is therefore a remarkable result of the expression studies presented here ([fig. 4](#evx046-F4){ref-type="fig"}) that the lack of up to 32 N-terminal aa of ubiquitin can be functionally replaced by viral C protein derived sequences, yet still allow for processing of the fusion proteins by cellular proteases, though in an inefficient manner.

Taken together, the results of the present study demonstrate that nonreplicative viral RNA recombination does not require the efficient translation of viral proteins and provide evidence for a remarkable flexibility regarding the structure of the pestivirus C protein. Future studies will focus on the identification of cellular factors putatively involved in nonreplicative RNA recombination.
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